Gain new in-vivo insights into the mechanism of action of your drug through co-implantation of human tumor cells with non-malignant tumor-infiltrating cells to recapitulate the pathological communication between different cell types in the tumor microenvironment.
Test a variety of cell lines derived from tumors from different anatomical locations to screen alternative indications to achieve the highest therapeutic potential.
Find the best treatments to combine with your drug candidate by screening a large number of combinations in multiple CDX models, with or without the addition of non-malignant tumor-infiltrating cells.
Ask your questions or request an introductory call.